Human locomotion is well documented, including gait changes due to different pathologies and normal ageing [1±3]. Most of the published literature focuses, however, on steady-state locomotion: The participants are analysed while walking at a normal rhythm. But locomotion is not limited to steady-state body transportation. It needs to be adapted to a permanently changing environment and therefore requires an efficient control of postural stability. Velocity changes and stopping are examples of such adaptive processes. Despite the fact that daily activities require the ability to stop, only a handful of studies have investigated gait termination processes [4±6]. Terminating gait puts special demands on postural control, as a transition occurs from a dynamic situation (walking) to a quasi-static situation (standing). 
During the transition period, the central nervous system must control the development of appropriate braking forces, their directions and magnitude, so that a precise positioning of the centre of mass (COM) within the base of support is achieved. Hence, in order to terminate gait successfully a precise integration and co-ordination of sensory information, visual inputs and muscle activity is necessary. Normal physiological ageing results in a slowing down of neuronal processing and transmission of information, combined with decreased sensory information due to neurone loss [7±10]. Thus, situations in daily life that demand quick adaptation become more difficult with increasing age [11, 12] .
Furthermore, pathologies are much more likely to occur with increasing age. Pathologies, such as arthritis and diabetes, can cause gait disorders [13, 14] . It is therefore reasonable to assume that they also influence gait termination. Diabetes is one of the most common chronic diseases, with angiopathy, retinopathy, nephropathy and neuropathy as its main consequences [15±18]. The influences of peripheral neuropathy on gait and posture have been the topic of many studies [13, 19, 20] . They all agree that diabetic persons affected with peripheral neuropathy are more impaired than non-affected diabetic control subjects matched for age or persons without diabetes matched for age. Research on postural control (standing) shows that persons affected with diabetes and peripheral neuropathy show an increased anterior/posterior (A/P) and medio/lateral (M/L) centre of pressure (COP) range [13, 21] . Increased postural sway is usually a sign of greater instability [9, 10] , further supported by the high risk factor of fall among independent elderly affected by peripheral neuropathy [22, 23] . Other studies document that affected persons show a prolonged reaction time, slower walking velocity and a shorter stride length [19] . They are also 15 times more likely to report injuries during walking when compared to a non-neuropathic control subjects and hence feel significantly less safe in unusual conditions [24] .
Other investigators were among the first to analyse rapid stopping behaviour and sudden turns in healthy elderly people [25±27]. They showed that in ninety-nine percent of cases, the elderly subjects fail to turn suddenly because of an inability to control the forward momentum in the available time [25] . Elderly people need significantly more time to execute a sudden stop than young people [26] . This can be attributed to the lengthened first phase of their responses and resulted in a higher post-cued acceleration. But a higher post-cue acceleration is not desirable for a sudden stop. Bearing in mind the fixed distance, it would either take more time to decelerate the whole body or require a larger force. Only elderly men were capable of partly compensating for this higher acceleration by developing a higher deceleration in the initial part of the deceleration phase [27] . This deceleration was also significantly higher when compared with young men. The authors point out that a possible reason for the gender differences found among the elderly participants could be due to the fact that elderly women are less able to develop ankle torque rapidly [28] .
Little is known, however, about gait termination and its characteristics in the elderly population. Investigations of two key biomechanical parameters, the COP and centre of mass (COM), during goal-oriented gait termination in elderly people have not been reported so far. Furthermore, gait termination data for elderly subjects with diabetes and impaired foot sensitivity is lacking. Therefore, the purpose of the study was to quantify the biomechanical characteristics of goal-oriented gait termination and to establish the effect of diabetes. The COP and COM maximal overshoots, which occur during the gait termination process, have been analysed in particular. These overshoots are an indicator of co-ordination abilities and the efficiency of postural stabilization. The larger the overshoots during the gait termination process, the more difficult it was for the person to stop and maintain his or her equilibrium. It has been hypothesised that Type II diabetic persons with reduced foot sensitivity due to peripheral neuropathy exhibit larger COP and COM overshoots in A/P and M/L directions during stopping than healthy control subjects. Furthermore, the foot sensitivity and also the A/P COM velocity should correlate with the size of the COP and COM overshoots.
Subjects and methods
This project was approved by the Research Ethics Committee of the Sherbrooke Geriatric University-Institute. All participants gave their written consent.
Participants. Two groups (healthy and Type II diabetic elderly persons) were formed according to a non-probabilistic sampling design. The participants were recruited from the population of the city of Sherbrooke, Quebec, Canada, and the surrounding area. Each group was composed of 15 participants. Because of sex differences in gait, men and women were equally represented in each group according to the following eligibility criteria.
Participants were included if they were aged between 60 and 75 years and able to walk unassisted. The healthy elderly participants were matched according to age ( 2 years), sex and body mass index (BMI) with the Type II diabetic persons. Care was taken not to violate the standard BMI classification of normal, over-weight and obese. The final acceptance was made on the result of measurements of fasting plasma glucose to ascertain whether they were free from diabetes. In order to exclude the possibility that the healthy elderly participants might have peripheral neuropathy due to causes other than diabetes, this group underwent a clinical examination using the scoring system previously developed [29] . This test is a global indicator of neurological status (sen-sory and motor) in the lower extremities. It includes, among other tests, pin-prick and light-touch sensation, sensory capacities of the ankle and the muscle strength of the gastrocnemius and extensor hallucis longus. The general scoring system is 0 point = no abnormalities, 2 points = impaired sensation in comparison with proximal sensation and 4 points = no sensation. In addition, the healthy elderly participants' vibration sensitivity threshold was also measured. The vibration sensitivity threshold (VST) was measured with the Vibrameter, Type IV (Somedic AB, Sweden). The VST was fixed according to the methods of limits (MOL) [30] . The threshold was detected by applying an increasing and decreasing vibration stimulus at the dorsal part of the big toe. The tested person identified this threshold as the minimal detectable amplitude of the applied vibration. The vibration was measured in microns and thereafter the age-corrected deviations from the mean (DfM) were calculated as indicated by the manufacturer. These age-corrected values were calculated using the regression equations based on the results of other investigators [31] who established normative values for the VST. The reported results are therefore adjusted with respect to the established values of this normative population and hence indicate the deviation from the population mean. This sets the results into a broader context.
The participants with Type II diabetes were included only if they had been diagnosed with peripheral neuropathy. The diagnosis of diabetic polyneuropathy was verified by clinical examination using the scoring system and described above [29] . In addition, a pronounced reduced vibration sensitivity had to be present. A person was considered as having this reduced vibration sensitivity when the measured value of at least one foot was more than two standard deviations above the mean of the normative population. Preference was given to non-invasive testing procedure and therefore electrodiagnostic tests for nerve function were not done.
The exclusion criteria were all factors that negatively influence gait and hence were also expected to negatively influence gait termination. Participants were excluded from the study if they had musculo-skeletal defects or any cardiac diseases (healthy elderly and diabetic persons), neurological defects (healthy elderly participants), neurological defects other than polyneuropathy (diabetic participants) or diabetes mellitus Type I or II (healthy elderly participants). The absence of diabetes in the healthy elderly group was tested by a fasting plasma glucose determination (FPG), with a normal range being between 3.8±6.1 mmol/l [18] . Furthermore, participants were excluded if their visual acuity was below 6/21 (metric) of the Snellen acuity chart, the threshold for low vision [32] . The sociodemographic and anthropometric characteristics of the participants are summarised in Table 1 .
Definition of COP and COM maximal overshoots and foot placement. The COP and COM overshoots were measured once the participant reached a final stop. This was the case when both feet were stationary. Biomechanically, the end of gait termination is, however, defined as an A/P COM velocity lower than 0.05 m/s [25] . The overshoots of both the COP and COM trajectories in A/P and M/L directions were measured with respect to the motion area centre (Fig. 1 ). They were calculated with a customised programme, which allowed a visual identification of the overshoots. The motion area centre was also defined visually. It represents the centre of the motion area that the COP and the COM cover during quiet standing following gait termination. As the participants were asked to stand still for at least 15 s after they reached the final stop, this motion area was well defined.
The foot placement at gait termination defines the base of support. In our study, it was approximated as a rectangle. The width equals the maximal M/L distance between the furthest lateral points of each foot, i. e. between the heads of the fifth metatarsals. The length equals the maximal A/P distance between the tip of the big toe and the contra-lateral heel. It is to be noted that the calculated base of support overestimates the effective base of support, as the participants were not required to place their feet in parallel at stop. Because no calculations of the COP and COM overshoots in relation with the base of support were done, this approach of presenting the base of support is adequate. The foot placement was calculated via a customised programme at HC3 (Fig. 2) .
Data collection procedure. In a preliminary session, the prospective diabetic participants were tested for the presence of peripheral neuropathy by using the instruments and tests described above. For both groups, visual acuity, height and weight were measured before the gait termination data collection. In order to determine the COM location, ten infra-red markers were placed on the participant's body at specific anatomical points: big toes, medial malleoli, patellae, trochanter major (frontal plane position), acromii. In addition, eight digitised points, four on each foot, helped to identify the exact foot position at HC3. To avoid the hip markers being hidden by the arm-swing, the participants were asked to hook their thumbs into the belt used to attach the connector units of the system. A task familiarisation period preceded the experiment to ensure that none of the marker adhesives impeded the participants' movements. During this period, the optimal starting position was also determined to ascertain whether the participant's feet were on the force plates.
The experiment itself consisted of at least eight successful trials from whom five were chosen for further data analysis according to a standardised procedure. The participants were simply asked to walk at their preferred walking pace along an indicated walkway and to stop in front of the marked stopping line (Fig. 2) . They had roughly three meters to walk before one of their feet reached the first force platform. They were requested to stay immobile after full stop was reached until the sampling trial was finished. This allowed the motion area of the COP and the COM during quiet standing to be calculated.
Two camera towers of the OPTOTRAK-3020 optical system, Northern Digital, Waterloo, Canada, were used to register limb movements. Two force plates (OR6±5-1000, manufactured by AMTI, Watertown, Watertown, Mass., USA) recorded ground reaction forces during the stopping task. Both data collecting systems sampled at 60 Hz.
Data and statistical analyses. The gait termination process was divided into two phases: the Approach and the Stopping Phases. The Approach Phase lasts from the first heel contact (HC1) to the second heel contact (HC2) (Fig. 2) . The Stopping Phase begins with HC2 and ends when the A/P COM velocity was lower than 0.05 m/s, the definition of a full stop [25] . This phase includes the third heel contact (HC3), the event at which gait visually terminates.
These definitions are mainly based on the results of other investigators [6] . These authors divided the stopping time into three phases. Phase 1 was initiated by the left foot, which released the stopping signal and completed with the right heel contact. During this time a 10 % reduction in gait velocity was achieved. Phase 2 was the main braking phase (right heel contact and second left heel contact) with a 73 % reduction in gait velocity during this second step. Phase 3 included the fine-tuning of the COM by the COP. During Phase 3, the COM was brought into the final position, a position equivalent to standing still. Phase 1 of these investigations corresponds to the Approach Phase. The phases 2 and 3 proposed by these investigators have, however, been combined in this study under the heading of the Stopping Phase. This combination is the logical conclusion of the previous results. As mentioned above, the main braking occurred during phases 2 and 3, hence these phases represent the Stopping Phase.
The A/P maximal forces, their timing and the A/P COM velocity were analysed during the entire gait termination process, i. e. the Approach and the Stopping Phase. Force plate data were time normalised so that HC1 to TO (toe off), which represents the stance phase of the Approach Phase, totalled 100 %. Furthermore, the Stopping Phase was normalised to 100 % using a 3-point-rubber banding method (Matlab, The Math Works, Natick, Mass., USA).
Due to the non-parametric data distribution, the results are expressed as median and semi-interquartiles (continuous variables) or as frequency and percentage (categorical variables). Results of both groups were compared by either a Wilcoxon Signed Ranks test or by a chi-squared test. For the graphical representation of the results, the mean and the standard deviations are, plotted by convention. To establish the mutual relationship of the COP and COM overshoots, the A/P velocity and the vibration sensitivity thresholds, the Spearman's correlation coefficient r was calculated. A p value of less than 0.05 was accepted as being significant. All statistical analyses were carried out using the statistics software package SPSS for Windows (Standard Version 8.0 of SPSS Inc., Chicago, Ill., USA). 
Results
The participant sociodemographic characteristics (Table 1) show that both groups were similar in age, weight, height, BMI and also smoking status, although slightly more of the elderly Type II diabetic subjects with peripheral neuropathy smoked. The participants were also equal in their self-perceived activity level, but significantly different in self-perceived health status (p = 0.003). All elderly Type II diabetic subjects were affected by peripheral neuropathy (p < 0.001) and also showed a significantly reduced vibration sensitivity threshold (VST) (p = 0.001). In contrast to this group, the VST of the healthy elderly subjects was excellent. Their general vibration sensitivity value was situated roughly 1 deviation below the mean of the normative population for this age group.
At the beginning of the Approach (HC1) and the Stopping Phases (HC2), the Diabetic A/P COM velocity of the elderly Type II diabetic subjects differed significantly from that of the healthy elderly subjects (Table 2, Fig. 3 ). Only at HC3 were the differences in the A/P COM velocity of the two groups insignificant. Both groups placed their feet in a similar manner in order to terminate gait, resulting in an almost identical base of support (p = 0.865). The COP overshoot of the elderly Type II diabetic subjects in the A/P direction (p = 0.027) was, however, only statistically significantly larger than that in the healthy elderly subjects but had no clinical evidence. This contrasts with the COP overshoot in the M/L direction (p = 0.029): The M/L COP overshoot was significantly (statistically and clinically) larger in the elderly Type II diabetic subjects than in the healthy elderly subjects (Table 2) . There was no statistical difference in the A/P and M/L COM overshoots between the two groups.
The Approach Phase. The maximal braking force F 1 of the healthy elderly subjects (±1.59 N/kg 0.23) was larger than F 1 of the elderly Type II diabetic subjects (±0.98 N/kg 0.28) (p = 0.011) (Fig. 4) . The maximal propelling force F 2 , however, was similar in both groups (Diabetic subjects 0.68 N/kg 0.09, healthy subjects 0.76 N/kg 0.21; p = 0.820). The transi- The Stopping Phase. The maximal stopping force F 3 of the healthy elderly subjects (±1.56 N/kg 0.33) was again larger than that observed for the elderly Type II diabetic subjects (±1.14 N/kg 0.22) (p = 0.008) (Fig. 5) . The results of the different relative times (t 5 , t 6 and t 7 ) contrast, however, with the results of the Approach Phase. There was no significant difference between the two groups. For the elderly Type II diabetic subjects, HC3 occurred at 52 % 4.5 (t 5 ) of the Stopping Phase whereas HC3 of the healthy elderly subjects occurred at 50 % 4 (p = 0.220). The maximal stopping force was reached in the elderly Type II diabetic subjects at 24 % 9 of the Stopping Phase (t 6 ) versus 17 % 10 in the healthy elderly subjects (p = 0.124). In both groups, there are no correlations between the A/P COM velocities measured at HC1, HC2, HC3 and the COP and COM overshoots in both directions. In the healthy elderly subjects, the Spearman's correlation coefficient r ranged from 0.467 (A/P COM velocity at HC1 and A/P COP overshoot; p = 0.079) to 0.168 (A/P COM velocity at HC3 and M/L COM overshoot; p = 0.551). In the elderly Type II diabetic subjects, the corresponding correlation coefficients were 0.109 ( The results of the A/P COM velocities confirm the general consensus that elderly diabetic people affected with peripheral neuropathy walk more slowly than their healthy counterparts matched for age [19] . This slowness could be observed even during the Approach Phase and, in part, during the Stopping Phase. Only from HC3 onwards, the event at which gait is visually terminated, is the corresponding A/P COM velocity nearly equal in both groups. The smaller maximal braking force F 1 and the longer relative time taken to develop this force (t 2 ) indicates that the elderly Type II diabetic subjects do not seem to have initiated their stopping process during the Approach Phase as the elderly healthy people do. Two possible reasons for this situation could exist. First, because of their significantly slower walking velocity, elderly Type II diabetic subjects might not need to start their stopping procedure during this phase. It might be sufficient for them to stop their gait completely during the Stopping Phase itself. The altered locomotor strategy also suggests that elderly Type II diabetic subjects have adopted a`slowness strategy'. This would allow them to reduce their disequilibrium so they might have more time to react. Second, the difference observed in the Approach Phase might be disease-induced as a possible result of the declined sensori-motor integration. Diabetic subjects affected with peripheral neuropathy show a prolonged reaction time [19, 33] . The prolonged t 2 in the elderly Type II diabetic subjects would agree with the published literature. The same applies for t 6 . It would not explain, however, the near similarity of (t 1 + t 4 ) in the elderly healthy and diabetic subjects. The rela- [5] . Reduced propelling forces during the Approach Phase reflect the roll to a stop, a fact, which applies to both groups. The characteristic prolonged reaction time in diabetic subjects might be more pronounced during active than during passive periods. This might explain why t 4 is not different between the elderly diabetic and healthy subjects.
The A/P and M/L COP overshoots are larger in the elderly diabetic subjects than in the healthy elderly subjects, demonstrating that the elderly diabetic subjects have difficulties in precisely co-ordinating their final stopping phase. Furthermore, the larger COP overshoots of the elderly diabetic subjects result in a larger motion area. Of note, the foot placement for both groups is very similar. Posture analyses have shown that the functional base of support diminishes with age [35, 36] . In addition to the age-related reduced functional base of support, elderly diabetic subjects have to cope with diminished sensory information. As the quality of sensory information decreases, postural control is increasingly difficult and requires a wider margin of safety [10] . Taking these results into account, the demonstrated larger A/P and M/L COP overshoots reveal that the elderly diabetic subjects are closer to their stability limit than the healthy elderly subjects. In other words, they become less tolerant of unexpected environmental changes, which might occur during the transition period and hence would require quick adaptations.
The results of this study also show that the impact of peripheral neuropathy seems to be partly compensated for by walking velocity. Although neither of the correlations between the VST and the COP and COM overshoots in either direction reached the level of significance, the negative effect of peripheral neuropathy could be observed. This effect was, however, masked by mechanisms, which help to control the COP and COM overshoots. One of these mechanisms is the`slowness strategy'. The elderly diabetic subjects walked with a significantly slower walking velocity compared with the elderly healthy subjects. Therefore, neuropathy as a whole has a negative effect on the walking characteristics. It has to be remembered that reduced vibration sensitivity (VST) is only one feature of neuropathy. It could be that other characteristics such as reduced nerve conduction velocities, reduced muscle forces, especially plantar flexor muscles, or a combination of the different characteristics could have a larger effect on the overall stopping behaviour than VST alone. The results obtained therefore have to be interpreted with caution.
Unexpectedly, there is no relation between the A/P COM velocity and the COP and COM overshoots. This could be explained by the fact that all participants were allowed to choose their preferred walking speed. Walking speed is influenced by external criteria, such as task and walking distance (in the present case, the relatively short distance that could have restricted the participants in fully developing their normal walking speed) and by internal criteria such as age and health status. These criteria might have lead to a walking speed that enables the participants to control their COP and COM trajectories as shown. Velocity controlled trials are, however, necessary to establish the lack of effect of A/P COM velocity on the COP and COM overshoots.
It has been assumed that the main stopping procedure occurs in the A/P direction. Therefore, our study's ground reaction forces and COM velocity analyses were limited to this direction only. An additional limit of the study is the lack of muscle strength data for the plantar flexors. It has been shown that development of rapid ankle torques is impaired in elderly people and is further reduced in people with diabetes [28, 37] . In retrospect, another useful tool would have been electromyographic (EMG) recording. EMG data combined with actual muscle strength might have helped to interpret the COP and COM overshoot differences shown.
In conclusion, the study documents that differences between elderly Type II diabetic people affected with peripheral neuropathy and healthy elderly people also exist in easy goal-oriented every-day stopping conditions. The differences are expressed in a slower A/P COM velocity during the entire Approach Phase and during most subcomponents of the Stopping Phase. Despite the slower walking velocity, the A/P and M/L COP overshoots of the elderly Type II diabetic subjects are larger than in the elderly healthy subjects. Therefore, the co-ordination abilities of elderly Type II diabetic subjects are impaired, leading to reduced stability during the critical transition from the dynamic to the quasi-static condition. They are therefore at a higher risk of falling.
In the future, gait termination tests might be used as an easy clinical test to establish dynamical instability problems. Almost every pathology, including diabetes, impairs postural stability. These instabilities are not always obvious during steady state, unre-strained locomotion. Gait termination, as a transient phenomenon, is able to exhibit the underlying impairments. It might therefore have the potential to be used as a clinical testing instrument.
